These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28017833)

  • 41. Atopic dermatitis: from new pathogenic insights toward a barrier-restoring and anti-inflammatory therapy.
    Simon D; Kernland Lang K
    Curr Opin Pediatr; 2011 Dec; 23(6):647-52. PubMed ID: 21970829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.
    Choi JK; Oh HM; Lee S; Park JW; Khang D; Lee SW; Lee WS; Rho MC; Kim SH
    Toxicol Appl Pharmacol; 2013 May; 269(1):72-80. PubMed ID: 23499868
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novelties in atopic dermatitis research.
    Ferrer E
    Drug News Perspect; 2008 Oct; 21(8):465-8. PubMed ID: 19034353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Not Available].
    Barbarot S; Aubert H
    Ann Dermatol Venereol; 2017 Jan; 144 Suppl 1():S14-S20. PubMed ID: 29221585
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Downregulation of immunological mediators in 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions by hydrocortisone-loaded chitosan nanoparticles.
    Hussain Z; Katas H; Mohd Amin MC; Kumolosasi E; Sahudin S
    Int J Nanomedicine; 2014; 9():5143-56. PubMed ID: 25395851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitory effects of polysaccharide-rich extract of Phragmites rhizoma on atopic dermatitis-like skin lesions in NC/Nga mice.
    Nam Y; Chung YH; Chu LY; Lee HS; Park ES; Hwang KW; Kim DS; Kim HD; Je HD; Shin YK; Jeong JH
    Life Sci; 2013 May; 92(14-16):866-72. PubMed ID: 23517777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Genetic risk of atopic dermatitis. Epidermal barrier and immunological dysregulation].
    Yazdi AS
    Hautarzt; 2012 Feb; 63(2):161-2. PubMed ID: 22457879
    [No Abstract]   [Full Text] [Related]  

  • 48. Cellular and molecular mechanisms in atopic dermatitis.
    Oyoshi MK; He R; Kumar L; Yoon J; Geha RS
    Adv Immunol; 2009; 102():135-226. PubMed ID: 19477321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Establishment of a Mouse Model of Atopic Dermatitis by Deleting Ikk2 in Dermal Fibroblasts.
    Nunomura S; Ejiri N; Kitajima M; Nanri Y; Arima K; Mitamura Y; Yoshihara T; Fujii K; Takao K; Imura J; Fehling HJ; Izuhara K; Kitajima I
    J Invest Dermatol; 2019 Jun; 139(6):1274-1283. PubMed ID: 30670308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene expression analysis of atopic dermatitis-like skin lesions induced in NC/Nga mice by mite antigen stimulation under specific pathogen-free conditions.
    Heishi M; Imai Y; Katayama H; Hashida R; Ito M; Shinagawa A; Sugita Y
    Int Arch Allergy Immunol; 2003 Dec; 132(4):355-63. PubMed ID: 14707467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New insights into atopic dermatitis.
    Leung DY; Boguniewicz M; Howell MD; Nomura I; Hamid QA
    J Clin Invest; 2004 Mar; 113(5):651-7. PubMed ID: 14991059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aspartame Attenuates 2, 4-Dinitrofluorobenzene-Induced Atopic Dermatitis-Like Clinical Symptoms in NC/Nga Mice.
    Kim GD; Park YS; Ahn HJ; Cho JJ; Park CS
    J Invest Dermatol; 2015 Nov; 135(11):2705-2713. PubMed ID: 26099025
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The potential role of impaired Notch signalling in atopic dermatitis.
    Melnik BC
    Acta Derm Venereol; 2015 Jan; 95(1):5-11. PubMed ID: 24853951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PPARgamma expression profile and its cytokine driven regulation in atopic dermatitis.
    Dahten A; Mergemeier S; Worm M
    Allergy; 2007 Aug; 62(8):926-33. PubMed ID: 17620071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigallocatechin-3-gallate improves Dermatophagoides pteronissinus extract-induced atopic dermatitis-like skin lesions in NC/Nga mice by suppressing macrophage migration inhibitory factor.
    Noh SU; Cho EA; Kim HO; Park YM
    Int Immunopharmacol; 2008 Sep; 8(9):1172-82. PubMed ID: 18602062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of filaggrin loss-of-function mutations in atopic dermatitis.
    O'Regan GM; Irvine AD
    Curr Opin Allergy Clin Immunol; 2008 Oct; 8(5):406-10. PubMed ID: 18769192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An atopic dermatitis-like skin disease with hyper-IgE-emia develops in mice carrying a spontaneous recessive point mutation in the Traf3ip2 (Act1/CIKS) gene.
    Matsushima Y; Kikkawa Y; Takada T; Matsuoka K; Seki Y; Yoshida H; Minegishi Y; Karasuyama H; Yonekawa H
    J Immunol; 2010 Aug; 185(4):2340-9. PubMed ID: 20660351
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lactobacillus plantarum NCIMB8826 ameliorates inflammation of colon and skin in human APOC1 transgenic mice.
    Mariman R; Reefman E; Tielen F; Persoon-Deen C; van de Mark K; Worms N; Koning F; Nagelkerken L
    Benef Microbes; 2016; 7(2):215-25. PubMed ID: 26689228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Etiopathogenesis of atopic dermatitis--an overview.
    Pastar Z; Lipozencić J; Ljubojević S
    Acta Dermatovenerol Croat; 2005; 13(1):54-62. PubMed ID: 15788148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specific substance of Maruyama (SSM) suppresses immune responses in atopic dermatitis-like skin lesions in DS-Nh mice by modulating dendritic cell functions.
    Mitsuishi T; Kabashima K; Tanizaki H; Ohsawa I; Oda F; Yamada Y; Halifu Y; Kawana S; Kato T; Iida K
    J Dermatol Sci; 2011 Sep; 63(3):184-90. PubMed ID: 21708453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.